The Innovative Medicines Initiative (IMI 2) - Call 10

The Innovative Medicines Initiative (IMI) has launched a new Call for proposals

Call description:

Call ID: H2020-JTI-IMI2-2016-10-two-stage

Action Type: RIA – Research and Innovation Actions

The Call includes the following topics:

- Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people    with diabetes by combining databases from clinical trials

- Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes     programme)

- Topic 3: Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported                   outcomes; biomarkers; and chronic pelvic pain)

- Topic 4: Creation of a pan-European paediatric clinical trials network

- Topic 5: Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid        during development and commercial cell culture processes

- Topic 6: Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)

- Topic 7: Patient perspectives in medicines lifecycle

- Topic 8: Personalised medicine approaches in autism spectrum disorders

Deadline for submitting short proposals: 21/03/2017

More information:

-The Call text, as well as details of how to apply, can be found on the respective web page.

-Webinars:

There have also been several webinars that you can download on this page: Webinars on IMI 2 Call 10

There will be another webinar with the rules and procedures that will be necessary for this convocatòira on 9 January.

-Partners search tool:  IMI 2 - CALL 10 2017